fbpx
Sunday, August 14, 2022
Home Blog
The U.S. Food and Drug Administration (FDA), will be reviewing Genetech’s Tecentriq (atezolizumab) matched with the chemotherapy drug Abraxaine (nab-paclitaxel) and carboplatin for metastatic non-squamous non-small cell lung cancer treatment. The drugs target demographic will be NSCLC patients with no mutations...
In a published study, found in Nature Genetics, researchers discovered that tumors with more mutations had a better outcome, if treated with immunotherapy. The “Tumor mutational load predicts survival after immunotherapy across multiple cancer types”...
Keytruda (pembrolizumab) is an immune checkpoint inhibitor that gives patients with certain cancers another treatment option. Although, Keytruda has had successful outcomes, its use has created a roadblock, when trying to determine the response or reaction a tumor...
Cancer is one of the world's leading causes of death, accounting for almost 10 million fatalities in 2020. It does not discriminate and affects people of all ages, races...
Since treatment for early stage breast cancer is becoming more limited and particular, it is starting to take a great financial toll on a lot of patients. Researchers from the University of Michigan Rogel Cancer Center are working on a...
Alex Trebek recently spoke out about his battle with cancer and how it has affected his mental health. Trebek says his doctor told him that one of the symptoms he could have from his stage 4 pancreatic...
A clinical trial at Tufts University recently showed success in treating osteosarcoma in dogs. Truman, a Bernese Mountain dog, was limping for a few days. When his owners became worried, they got him an...
A new mouse study has shown that cancer patients who take a certain antibiotic before treatment may see better results! Even with advancements in treatment, cancer is still the second highest cause of death...
After many people questioned evidence of a link between processed meat and cancer of the bowel, colon and rectum, scientists have published a study of their meta-analysis on the classification of processed meat as a carcinogen.
CHIPSA Hospital, the renowned immunotherapy clinic in Tijuana, Mexico, recently announced the launch of three immune-stimulating cancer treatments. The hospital currently has an entire Immune™ Cellular program that uses cell therapy to treat cancer....

EDITOR PICKS